ArticleWorld journal of clinical cases2025
Endoscopic management of intragastric balloon related gastric outlet obstruction: A case report and review of literature.
Article in World journal of clinical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity remains a significant global health concern, and intragastric balloons (IGBs) offer a minimally invasive weight loss option for patients who fail lifestyle and pharmacotherapy interventions. IGBs can cause complications ranging from mild symptoms to severe issues like gastric outlet obstruction (GOO). This report discusses a 39-year-old woman who presented with clinical and radiological features of GOO post Silimed IGB placement. CASE SUMMARY: A 39-year-old woman presented to our institution with two-week history of abdominal pain, nausea and vomiting post prandially. This was in the context of a Silimed IGB placement two weeks prior to presentation for weight loss in the context of obesity. A computed tomography of the abdomen demonstrated the IGB device in the body and prepyloric region, with proximal dilatation of the body and fundus of the stomach which contained gastric contents. Due to concerns for GOO, the IGB was removed endoscopically with subsequent symptom alleviation. In addition to this, we performed a literature search of cases of IGB related GOO using the PubMed and Web of Science databases from inception date to the August 26, 2024. A total of 27 articles were included in the analysis, identifying 29 cases of IGB-related GOO. These patients commonly presented with nausea, vomiting and abdominal pain, with symptom onset varying from 3 days to 18 months post IGB insertion. Abdominal computed tomography was the primary diagnostic tool and endoscopic removal was the standard treatment modality.
conclusionThis is the first reported case of GOO caused by Silimed IGB. While effective for weight reduction, IGB-related GOO is a rare but serious complication, usually requiring endoscopic retrieval. Future research should aim to identify patient factors linked to this complication to enhance clinical-decision making and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.